10x Genomics, Inc. (TXG)
USD 13.42
(-8.83%)
USD 13.42
(-8.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 618.72 Million | 516.4 Million | 490.49 Million | 298.84 Million | 245.89 Million | 146.31 Million |
| Cost of Revenue | 209.41 Million | 120.38 Million | 74.09 Million | 58.46 Million | 61.03 Million | 28.66 Million |
| Gross Profit | 409.31 Million | 396.02 Million | 416.39 Million | 240.37 Million | 184.86 Million | 117.65 Million |
| Operating Expenses | 674.94 Million | 563.96 Million | 469.31 Million | 325.7 Million | 213.93 Million | 135.47 Million |
| Selling, General and Administrative Expenses | 343.33 Million | 298.3 Million | 257.56 Million | 202.32 Million | 130.83 Million | 87.93 Million |
| Research and Development Expenses | 270.33 Million | 265.66 Million | 211.75 Million | 123.37 Million | 83.09 Million | 47.53 Million |
| Other Expenses | - | -198 Thousand | -802 Thousand | 1.33 Million | -186 Thousand | -249 Thousand |
| Cost and Expenses | 884.36 Million | 684.35 Million | 543.4 Million | 384.16 Million | 274.96 Million | 164.13 Million |
| Operating Income | -265.32 Million | -167.94 Million | -52.91 Million | -85.32 Million | -29.07 Million | -110.76 Million |
| Interest Expense | 33 Thousand | 476 Thousand | 866 Thousand | 1.68 Million | 3.07 Million | 2.4 Million |
| Income Tax Expense | 6.33 Million | 4.02 Million | 4.5 Million | 8.25 Million | 218 Thousand | 87 Thousand |
| Earnings before Tax | -248.76 Million | -161.97 Million | -53.71 Million | -534.47 Million | -31.03 Million | -112.39 Million |
| Net Income | -255.09 Million | -166 Million | -58.22 Million | -542.73 Million | -31.25 Million | -112.48 Million |
| Earnings Per Share Basic | -2.18 | -1.46 | -0.53 | -5.37 | -0.80 | -8.40 |
| Earnings Per Share Diluted | -2.18 | -1.46 | -0.53 | -5.37 | -0.80 | -8.40 |
| Weighted Average Shares Outstanding | 117.16 Million | 113.85 Million | 110.34 Million | 101.15 Million | 39.06 Million | 13.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 117.16 Million | 113.85 Million | 110.34 Million | 101.15 Million | 39.09 Million | 13.39 Million |
| Gross Margin | 0.66 | 0.77 | 0.85 | 0.80 | 0.75 | 0.80 |
| EBIT Margin | -0.33 | -0.31 | -0.11 | -0.28 | -0.11 | -0.09 |
| Profit Margin | -0.41 | -0.32 | -0.12 | -1.82 | -0.13 | -0.77 |
| EBITDA | -205.11 Million | -128.48 Million | -24.59 Million | -513.77 Million | -20.88 Million | -106.08 Million |
| Earnings Before Tax Margin | -0.43 | -0.33 | -0.11 | -0.29 | -0.12 | -0.76 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 151.65 Million | 153.1 Million | 141 Million | 183.97 Million | 618.72 Million | 153.64 Million |
| Cost of Revenue | 45.26 Million | 46.2 Million | 45.43 Million | 77.91 Million | 209.41 Million | 58.11 Million |
| Gross Profit | 106.39 Million | 106.89 Million | 95.56 Million | 106.06 Million | 409.31 Million | 95.52 Million |
| Operating Expenses | 147.87 Million | 148.63 Million | 154.96 Million | 141.67 Million | 611.18 Million | 190.32 Million |
| Selling, General and Administrative Expenses | 81.7 Million | 83.03 Million | 84.67 Million | 86.12 Million | - | 82.41 Million |
| Research and Development Expenses | 66.17 Million | 62.91 Million | 67.93 Million | 55.55 Million | - | 107.9 Million |
| Other Expenses | 998 Thousand | -2.67 Million | -2.35 Million | 3.96 Million | -307 Thousand | -1.24 Million |
| Cost and Expenses | 193.13 Million | 194.84 Million | 200.4 Million | 219.58 Million | 820.59 Million | 248.43 Million |
| Operating Income | -41.48 Million | -41.73 Million | -59.39 Million | -35.61 Million | -201.86 Million | -94.79 Million |
| Interest Expense | 2000.00 | 1000.00 | 1000.00 | 8000.00 | 33 Thousand | 1000.00 |
| Income Tax Expense | 1.31 Million | 818 Thousand | 2.14 Million | 2.35 Million | 6.33 Million | 1.24 Million |
| Earnings before Tax | -34.43 Million | -37.07 Million | -57.8 Million | -46.59 Million | -248.76 Million | -91.74 Million |
| Net Income | -35.75 Million | -37.89 Million | -59.94 Million | -48.95 Million | -255.09 Million | -92.98 Million |
| Earnings Per Share Basic | -0.30 | -0.32 | -0.50 | -0.41 | - | -0.79 |
| Earnings Per Share Diluted | -0.30 | -0.32 | -0.50 | -0.41 | - | -0.79 |
| Weighted Average Shares Outstanding | 120.73 Million | 120.06 Million | 119.39 Million | 118.56 Million | 117.16 Million | 117.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.73 Million | 120.06 Million | 119.39 Million | 118.56 Million | 117.16 Million | 117.72 Million |
| Gross Margin | 0.70 | 0.70 | 0.68 | 0.58 | 0.66 | 0.62 |
| EBIT Margin | -0.16 | -0.20 | -0.34 | -0.13 | - | -0.60 |
| Profit Margin | -0.24 | -0.25 | -0.43 | -0.27 | -0.41 | -0.61 |
| EBITDA | -23.68 Million | -30.83 Million | -47.9 Million | -23.9 Million | - | -91.74 Million |
| Earnings Before Tax Margin | -0.27 | -0.27 | -0.42 | -0.19 | -0.33 | -0.62 |
PLX
NBG6
2440
EMAMIREAL
4001
0IGA